Arrowhead Pharmaceuticals Inc (ARWR)

Operating return on assets (Operating ROA)

Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Operating income (ttm) US$ in thousands 98,346 -107,963 -118,554 -625,947 -601,080 -547,207 -473,769 -299,413 -205,002 -180,502 -150,708 -157,320 -178,507 -159,560 -118,519 -188,304 -149,037 -134,273 -118,351 -112,359
Total assets US$ in thousands 1,385,300 1,380,610 1,573,500 1,013,690 1,139,800 883,759 955,150 626,286 765,552 795,856 891,308 891,489 691,939 751,782 703,575 638,539 710,148 734,927 756,795 499,251
Operating ROA 7.10% -7.82% -7.53% -61.75% -52.74% -61.92% -49.60% -47.81% -26.78% -22.68% -16.91% -17.65% -25.80% -21.22% -16.85% -29.49% -20.99% -18.27% -15.64% -22.51%

September 30, 2025 calculation

Operating ROA = Operating income (ttm) ÷ Total assets
= $98,346K ÷ $1,385,300K
= 7.10%